Gary L. Crocker - 17 May 2022 Form 4 Insider Report for MERRIMACK PHARMACEUTICALS INC

Signature
/s/ Gary L. Crocker
Issuer symbol
N/A
Transactions as of
17 May 2022
Net transactions value
+$26,554
Form type
4
Filing time
19 May 2022, 16:05:14 UTC
Previous filing
16 May 2022
Next filing
23 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MACK Common Stock Purchase $1,147 +225 +0.19% $5.10 118,037 17 May 2022 See footnote F1, F2
transaction MACK Common Stock Purchase $25,407 +5,000 +4.2% $5.08 123,037 18 May 2022 See footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.94 to $5.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Remarks:

Chairman, President, and Treasurer